Vilin Bio Med (NSE:VILINBIO) Gross-Profit-to-Asset % : 18.20% (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Vilin Bio Med's annualized Gross Profit for the quarter that ended in Sep. 2023 was ₹56.31 Mil. Vilin Bio Med's average Total Assets over the quarter that ended in Sep. 2023 was ₹309.44 Mil. Therefore, Vilin Bio Med's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 was 18.20%.

Vilin Bio Med Gross-Profit-to-Asset % Historical Data

The historical data trend for Vilin Bio Med's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med Gross-Profit-to-Asset % Chart

Vilin Bio Med Annual Data

Trend

Mar20

Mar21

Mar22

Gross-Profit-to-Asset %

20.05

17.26

15.51

Vilin Bio Med Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Sep23
Gross-Profit-to-Asset %	-	-	-	24.86	18.20

Competitive Comparison of Vilin Bio Med's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Vilin Bio Med's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vilin Bio Med's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vilin Bio Med's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Vilin Bio Med's Gross-Profit-to-Asset % falls into.

Vilin Bio Med Gross-Profit-to-Asset % Calculation

Vilin Bio Med's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Mar. 2022 )	/	( (Total Assets (A: Mar. 2021 )	+	Total Assets (A: Mar. 2022 ))	/ count )
	=	21.281	/	( (138.914	+	135.583)	/ 2 )
	=	21.281	/	137.2485
	=	15.51 %

Vilin Bio Med's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Sep. 2023 )	/	( (Total Assets (Q: Sep. 2022 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
	=	56.306	/	( (0	+	309.444)	/ 1 )
	=	56.306	/	309.444
	=	18.20 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Sep. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Vilin Bio Med Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilin Bio Med (NSE:VILINBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Gross-Profit-to-Asset %

Traded in Other Exchanges

N/A

Address

Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009

Website

http://www.vilinbiomed.co.in

Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines